Z16.12
Extended spectrum beta lactamase (ESBL) resistance
Clinical Classification Guidelines
Excludes Type 2
- Methicillin resistant Staphylococcus aureus infection in diseases classified elsewhere (B95.62)
Medical Intelligence & Overview
Extended Spectrum Beta-Lactamase (ESBL) resistance refers to a condition where certain bacteria develop the ability to resist antibiotics known as beta-lactams. Beta-lactam antibiotics, including penicillins and cephalosporins, are commonly used to treat bacterial infections. When bacteria acquire ESBL enzymes, they can break down these antibiotics, making infections more difficult to treat. The ICD-10 code Z16.12 is used to classify cases involving ESBL resistance, providing important information for healthcare recording and research. This guide offers a patient-friendly overview of what ESBL resistance entails, its causes, symptoms, diagnosis, and approaches to management.
Causes & Symptoms
Clinical Causes: Prolonged or inappropriate use of antibiotics, which encourages bacteria to develop resistance Hospital-acquired infections, especially among patients with weakened immune systems or prior antibiotic treatments Transmission of resistant bacteria from person to person through contact or contaminated surfaces Colonization of bacteria in the gut or other body sites that develop resistance over time Use of antibiotics in agriculture and food production, contributing to resistant strains in the environment
Key Symptoms: Persistent or recurrent infections that do not respond to standard antibiotic treatment Signs of specific infections, such as urinary tract infections, bloodstream infections, or pneumonia Fever and chills accompanying the infection Localized pain, swelling, or discomfort depending on the site of infection In severe cases, sepsis or systemic illness may develop if bacteria spread widely
Diagnostic & Treatment
Diagnosis Path: Diagnosing ESBL resistance involves laboratory testing of bacterial samples obtained from infected sites. Key steps include:
Treatment Protocols: Managing infections caused by ESBL-producing bacteria requires tailored approaches, often involving:
Clinical Advice & FAQs
Billing Guidance
Is Z16.12 a billable ICD-10 code?
Yes, Z16.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report Z16.12?
Clinical documentation must specify the nature of Extended spectrum beta lactamase (ESBL) resistance and any associated comorbidities for accurate reporting.
Cite this Clinical Reference